Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Erste Sparinvest - ESPA Stock Biotec

+ Add to Watchlist

BIOTECT:AV

537.91 EUR 2.26 0.42%

As of 00:59:30 ET on 04/24/2015.

Snapshot for Erste Sparinvest - ESPA Stock Biotec (BIOTECT)

Year To Date: +34.39% 3-Month: +20.46% 3-Year: +51.64% 52-Week Range: 258.67 - 545.43
1-Month: +3.33% 1-Year: +102.31% 5-Year: +36.56% Beta vs MIGUBTEC: 0.91

Mutual Fund Chart for BIOTECT

No chart data available.
  • BIOTECT:AV 537.91
  • 1M
  • 1Y
Interactive BIOTECT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BIOTECT

ESPA Stock Biotec is an open-end investment fund incorporated in Austria. The Fund's objective is long-term capital growth. The Fund invests primarily in equity securities issued by larger biotechnology companies located in the United States, Europe and the Asian Pacific Region. The Fund invests approximately 70% of assets in the US, 25% in Europe and the remainder in Asia.

Inception Date: 04-17-2000 Telephone: +43 (0) 50100-0
Managers: HARALD KOBER
Web Site: www.erste-am.com

Fundamentals for BIOTECT

NAV (on 2015-04-24) 537.91
Assets (M) (on 2015-04-24) 247.48
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for BIOTECT

Dividend Type Income
Dividend Frequency Irreg
Last Dividend Net (on 2014-06-12) 3.62
Dividend Yield (ttm) 0.67

Fees & Expenses for BIOTECT

Front Load 4.00
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for BIOTECT

Filing Date: 02/27/2015
Name Position Value % of Total
Biogen Inc 56,430 20,637,573 9.624%
Celgene Corp 161,150 17,726,716 8.266%
Gilead Sciences Inc 170,600 15,851,263 7.392%
Amgen Inc 93,170 13,208,396 6.159%
Regeneron Pharmaceuticals Inc 33,240 12,446,140 5.804%
Vertex Pharmaceuticals Inc 78,050 8,350,344 3.894%
Illumina Inc 45,100 7,981,938 3.722%
Alexion Pharmaceuticals Inc 44,200 7,217,606 3.366%
BioMarin Pharmaceutical Inc 64,450 6,255,619 2.917%
Pharmacyclics Inc 28,070 5,452,541 2.543%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil